Presentation is loading. Please wait.

Presentation is loading. Please wait.

Flow diagram of study conduct.

Published byCoraline Lévesque Modified over 5 years ago

Similar presentations

Presentation on theme: "Flow diagram of study conduct."— Presentation transcript:

1 Flow diagram of study conduct.
Flow diagram of study conduct. A level-1 medicines review includes screening for any apparent problems with prescribed medicines. CAD, coronary artery disease; ENCOURAGE, Epidemiology of Northern Cardiovascular Outcomes and Underlying Risk of Atherosclerosis due to Genes and Environment (programme database at the Yorkshire Heart Centre in Leeds, UK); GP, general practitioner; NHS, National Health Service; RANI-1, First Reported Adherence versus Non-adherence Investigation. Rani Khatib et al. Open Heart 2019;6:e000997 ©2019 by British Cardiovascular Society

Download ppt "Flow diagram of study conduct."

Similar presentations

Nurse Co-ordinated Rapid Access Chest Pain Clinic

Nurse Co-ordinated Rapid Access Chest Pain Clinic
by Nadine Martel, James Lee, and Philip S. Wells

by Nadine Martel, James Lee, and Philip S. Wells
Proportion of Sudden Unexpected Death in North Carolina (SUDDEN) men and women with coronary artery disease (CAD) aged 56–64 years by source of medical.

Proportion of Sudden Unexpected Death in North Carolina (SUDDEN) men and women with coronary artery disease (CAD) aged 56–64 years by source of medical.
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Figure 1 Cardiovascular risk and disease across the life-course

Figure 1 Cardiovascular risk and disease across the life-course
Comparison of DNA rates between standard lists and BCSP lists across UK. BCSP, Bowel Cancer Screening Programme; DNA, did not attend; NHS, National Health.

Comparison of DNA rates between standard lists and BCSP lists across UK. BCSP, Bowel Cancer Screening Programme; DNA, did not attend; NHS, National Health.
MACE rate among CAD severity groups (total 0

MACE rate among CAD severity groups (total 0
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Coronary revascularisation rate (total 5

Coronary revascularisation rate (total 5
Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.

Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.
Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.

Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.
Frequency counts of exercise intensities routinely prescribed in programmes (n=194) grouped by method/scale. Frequency counts of exercise intensities routinely.

Frequency counts of exercise intensities routinely prescribed in programmes (n=194) grouped by method/scale. Frequency counts of exercise intensities routinely.
CT angiography results (vertical axis, N=count of patients): (A) total Coronary Calcium Score (CCS) (y-axis, Agatston Score), (B) coronary stenosis severity.

CT angiography results (vertical axis, N=count of patients): (A) total Coronary Calcium Score (CCS) (y-axis, Agatston Score), (B) coronary stenosis severity.
CT coronary angiography curved planar reconstruction of the left anterior descending coronary artery showing an atherosclerotic plaque with calcified and.

CT coronary angiography curved planar reconstruction of the left anterior descending coronary artery showing an atherosclerotic plaque with calcified and.
Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Baseline Characteristics

Baseline Characteristics
Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle ‘Plan-Do-Study-Act’ (PDSA) methodology. Integration.

Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle ‘Plan-Do-Study-Act’ (PDSA) methodology. Integration.

Similar presentations

Ads by Google